OMA Guidelines Bundle

Obesity Pharmacotherapy - Obesity Algorithm 2024

Obesity Medicine Association OMA GUIDELINES App Bundle brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1349812

Contents of this Issue

Navigation

Page 5 of 33

6 Effects of Concomitant Medications on Weight (cont'd) Concomitant Pharmacotherapy Hormones (cont'd) Variable effects on body weight: • Progestin contraceptives   ▶ Injectable or implantable progestins may have greatest risk for weight gain • Testosterone   ▶ May reduce percent body fat and increase lean body mass, especially if used to replace testosterone def iciency in men Anti-seizure Medications May increase body weight: • Carbamazepine • Gabapentin • Valproate • Pregabalin May decrease body weight: • Topiramate • Zonisamide Antidepressants May increase body weight (reports on body weight not always consistent): • Some tricyclic antidepressants (tertiary amines)   ▶ Amitriptyline   ▶ Doxepin   ▶ Imipramine   ▶ Dosulepin • Some selective serotonin reuptake inhibitors (e.g., paroxetine, citalopram) • Some selective serotonin and norepinephrine re-uptake inhibitors (e.g., venlafaxine) • Some irreversible monoamine oxidase inhibitors (MAOI) (e.g., isocarboxazid, phenelzine) • Trazodone • Mirtazapine • Brexpiprazole May decrease body weight: • Bupropion • Fluoxetine (variable) (cont'd)

Articles in this issue

Archives of this issue

view archives of OMA Guidelines Bundle - Obesity Pharmacotherapy - Obesity Algorithm 2024